fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management#:~:text=Today%2C%20the%20U.S.%20Food%20and,with%20type%202%20diabetes%20mellitus Ussher JR, Drucker DJ
The things that warrant a real conversation with a provider rather than waiting it out are severe vomiting that makes eating or drinking impossible, significant abdominal pain especially if it radiates to the back, fatigue that is not improving after the first several weeks or feels more severe than low energy, and any symptoms that feel genuinely wrong rather than just unpleasant
Marloes van HoutEmployee and shareholder of Novo Nordisk A/S
GLP 1 medications support weight loss, metabolic health, and blood sugar regulation by imitating a natural hormone in the body
For those interested in body composition research more broadly, some UK academic institutions are investigating the effects of incretin-based therapies on lean mass preservation during weight loss